Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

SARS-CoV-2 spike subunit 2–targeted vaccine could more effectively combat all human coronaviruses

In a new study, researchers evidenced that the S2 subunit of SARS-CoV-2 spike (S) could be an integral component of a pan-coronavirus vaccine.

29 Jul 2022

One Health approach for emergent and resurgent infectious diseases

A recent editorial published in The Lancet Microbe underscored the ‘One Health’ policy for surveilling emergent infectious diseases.

29 Jul 2022

Tannins as therapeutic agents against SARS-CoV-2

Researchers reviewed tannins as therapeutic agents against SARS-CoV-2.

29 Jul 2022

Study explores the role of endemic coronaviruses-induced cross-immunity in protection against severe COVID-19

A new study investigated whether prior exposure to coronaviruses induces cross-reactive immunity that protects adults from severe coronavirus disease 2019.

29 Jul 2022

Proteomics profiling of COVID-19 patients identifies dysregulated proteins and pathways

Researchers assessed the impact of SARS-CoV-2 infection and severity on coronary and Alzheimer’s disease pathways.

29 Jul 2022

Vaccination after COVID-19 recovery reduces reinfection risk by almost 50%

Researchers estimated the probability of SARS-CoV-2 reinfection following COVID-19 recovery. Additionally, they determined the effectiveness of the primary vaccination series in reducing the reinfection risk.

29 Jul 2022

To what extent did the COVID-19 booster strategy prevent infections and hospitalizations in US adults?

Researchers estimated the impact of different COVID-19 mRNA booster vaccinations in the United States during fall 2022.

29 Jul 2022

Knowledge, attitudes, and practices of medical professionals towards monkeypox in Italy

Researchers assessed the knowledge, attitudes, and practices (KAP) of healthcare workers (HCWs) towards monkeypox (MPX) in Italy.

29 Jul 2022

Moderna COVID vaccine is more effective in older and sicker veterans over time

Researchers report the higher effectiveness of the Moderna COVID-19 vaccine as compared to the Pfizer COVID-19 vaccine.

28 Jul 2022

Study highlights impaired ketogenesis as a potential confounder of severe COVID-19

In severe Covid-19 patients, the metabolism produces insufficient amounts of certain energy-rich compounds called ketone bodies. However, these energy carriers are needed by two important cell types in the immune system in order to fight the virus effectively.

28 Jul 2022

The global mutation landscape of the SARS-CoV-2 non-structural protein 1

Researchers describe the evolution of the SARS-CoV-2 non-structural protein 1 (NSP1).

28 Jul 2022

The bat-virus relationship examined

A new study examines the role of bats as reservoirs of several viruses and the factors that contribute to the emergence of these viruses.

28 Jul 2022

TMPRSS2 protein, a novel target for SARS-CoV-2 drugs

A new study reports the activity of a compound which inhibited TMPRSS2, ultimately preventing severe COVID-19.

28 Jul 2022

Predicting viral antibody escape using pre-pandemic data

A new study reports early prediction of SARS-CoV-2 immune evasion using EVEscape.

28 Jul 2022

Cross-reactive SARS-CoV-2 antibodies after exposure to avian coronavirus vaccine

Researchers identify SARS-CoV-2 cross-reactive antibodies in poultry farm workers exposed to the avian infectious bronchitis virus.

28 Jul 2022

Children strongly bonded to pets during COVID experienced more anxiety

Both a parent's and child’s attachment to pets appears to be a barometer of mental health during the COVID-19 pandemic.

28 Jul 2022

KHN’s ‘What the Health?’: Manchin makes a deal

The Democrats' on-again, off-again budget bill is apparently on again, and it's bigger than expected. In a surprise move, Senate Majority Leader Chuck Schumer announced an agreement with Sen. Joe Manchin (D-W.Va.) to expand the scope of the limited health bill that was headed to the Senate floor to also include climate change and some tax increases for corporations and certain wealthy Americans.

28 Jul 2022

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

SARS-CoV-2 spike subunit 2–targeted vaccine could more effectively combat all human coronaviruses

One Health approach for emergent and resurgent infectious diseases

Tannins as therapeutic agents against SARS-CoV-2

Study explores the role of endemic coronaviruses-induced cross-immunity in protection against severe COVID-19

Proteomics profiling of COVID-19 patients identifies dysregulated proteins and pathways

Vaccination after COVID-19 recovery reduces reinfection risk by almost 50%

To what extent did the COVID-19 booster strategy prevent infections and hospitalizations in US adults?

Knowledge, attitudes, and practices of medical professionals towards monkeypox in Italy

Moderna COVID vaccine is more effective in older and sicker veterans over time

Study highlights impaired ketogenesis as a potential confounder of severe COVID-19

The global mutation landscape of the SARS-CoV-2 non-structural protein 1

The bat-virus relationship examined

TMPRSS2 protein, a novel target for SARS-CoV-2 drugs

Predicting viral antibody escape using pre-pandemic data

Cross-reactive SARS-CoV-2 antibodies after exposure to avian coronavirus vaccine

Children strongly bonded to pets during COVID experienced more anxiety

KHN’s ‘What the Health?’: Manchin makes a deal

Weak antibody response yet robust cellular immunity identified in children after SARS-CoV-2 Omicron infection

New research points to multiple zoonotic origins of SARS-CoV-2

Evidence that the Huanan market in Wuhan, China, was the epicenter of the COVID-19 pandemic

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in